D. Slee

发表

Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels

D. Grigoriadis, S. Hoare, John A. Williams, 2009, Neuropsychopharmacology.

Selection, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists.

C. J. Loweth, M. Feher, D. Slee, 2007, Bioorganic & medicinal chemistry.

Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity.

D. Slee, W. Ripka, J. Yu, 2001, Journal of medicinal chemistry.

A synthetic approach to squalestatin 1

Joseph P. Adams, H. Abdel-Rahman, D. Slee, 1993 .

Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties.

D. Grigoriadis, S. Hoare, D. Slee, 2010, Bioorganic & medicinal chemistry letters.

2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.

J. Díaz, S. Lechner, D. Slee, 2008, Journal of medicinal chemistry.

Evaluation of KP‐1199: a novel acetaminophen analog for hemostatic function and antinociceptive effects

J. Bynum, A. Cap, R. Christy, 2021, Transfusion.

Selectivity in the Inhibition of HIV and FIV Protease: Inhibitory and Mechanistic Studies of Pyrrolidine-Containing .alpha.-Keto Amide and Hydroxyethylamine Core Structures

I. Ollmann, A. Wlodawer, Chi‐Huey Wong, 1995 .

Pyrrolopyrazinedione-based inhibitors of human hormone-sensitive lipase.

M. J. Newman, D. Slee, A. Bhat, 2003, Journal of medicinal chemistry.

2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents.

J. Díaz, S. Lechner, D. Slee, 2008, Journal of medicinal chemistry.

Inhibition of Fructose-1,6-bisphosphatase by a New Class of Allosteric Effectors*

M. J. Newman, H. Fromm, D. Slee, 2003, Journal of Biological Chemistry.

Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists.

J. Díaz, S. Lechner, D. Slee, 2008, Bioorganic & medicinal chemistry letters.

Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease.

J. Díaz, S. Lechner, D. Slee, 2008, Journal of medicinal chemistry.